Home | All reference

[RDF data]
Reference #10365

Resource URI: http://static.linkedct.org/resource/reference/10365
linkedct:PMid 11391165
linkedct:citation Eron JJ, Haubrich R, Lang W, Pagano G, Millard J, Wolfram J, Snowden W, Pedneault L, Tisdale M. A phase II trial of dual protease inhibitor therapy: amprenavir in combination with indinavir, nelfinavir, or saquinavir. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):458-61.
rdfs:label Reference #10365
foaf:page <http://www.ncbi.nlm.nih.gov/pubmed/11824950>
is linkedct:reference of <http://static.linkedct.org/resource/trials/NCT00002372>
linkedct:reference_id 10365 (xsd:int)
owl:sameAs <http://bio2rdf.org/pubmed:11824950>
rdf:type linkedct:reference